| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/04/2002 | CN1366888A Nano quicken the blood and disperse welling abscess preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366887A Nano amber dragon-embracing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366878A Texture screening granules containing active components |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 09/04/2002 | CN1090025C Medicated wine for treating pain in waist and lower extremities and rheumatic arthritis, and its producing method |
| 09/04/2002 | CN1090024C Method for preparation of medicine capable of improving sexual function, enhancing immunity and removing fatigue |
| 09/04/2002 | CN1090021C Preparation method and use of sulfated oligosaccharides |
| 09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/03/2002 | US6444789 CD16-II variants |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | US6444685 N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444665 Method for treating pain |
| 09/03/2002 | US6444663 Treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, and for the prevention of ischemic injury. |
| 09/03/2002 | US6444657 2-(phosphonomethyl)pentanedioic acid; 2-(2-sulfanylethyl) pentanedioic acid; epithelial tissue scarring, collagen vascular disease, fibroproliferation, connective tissue disorder, respiratory distress syndrome; tgf regulator |
| 09/03/2002 | US6444647 Composition comprising safe and effective amounts of vitamin b3 compound and additional skin care active selected from farnesol and/or phytantriol, and dermatologically acceptable emulsion carrier |
| 09/03/2002 | US6444639 Human chorionic gonadotrophin (hcg) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |
| 09/03/2002 | US6444443 Gene |
| 09/03/2002 | US6444434 Compounds inhibiting the activation of fx to fxa by tf/fviia. the compounds are anticoagulants. the invention also relates to a method of identifying a drug candidate. |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/03/2002 | CA1341387C Human manganese superoxide dismutase (hmn-sod) |
| 08/29/2002 | WO2002066978A2 Detection of compounds that modulate inflammatory responses |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066650A2 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066624A2 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066481A1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 08/29/2002 | WO2002066476A1 6-phenylbenzonaphthyridines |
| 08/29/2002 | WO2002066470A1 Substituted alkylamine derivatives and methods of use |
| 08/29/2002 | WO2002066463A1 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066460A1 Chemical compounds |
| 08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/29/2002 | WO2002066450A2 Anthrone derivatives and their use as ink inhibitors |
| 08/29/2002 | WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 08/29/2002 | WO2002066430A1 Tryptase inhibitors |
| 08/29/2002 | WO2002066420A2 Tryptase inhibitors |
| 08/29/2002 | WO2002066069A1 Remedies for inflammatory/tumor diseases |
| 08/29/2002 | WO2002066030A1 Medicinal compositions comprising diclofenac and ornoprostil |
| 08/29/2002 | WO2002066028A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | WO2002066026A2 Tramadol-based medicament |
| 08/29/2002 | WO2002066025A2 Combination of active ingredients consisting of the racemate of tramadol and of (+)-o-desmethyltramadol |
| 08/29/2002 | WO2002066002A2 Pharmaceutical formulation |
| 08/29/2002 | WO2002065859A1 Emulsions and aqueous dispersions of phytosterols |
| 08/29/2002 | WO2002047668A3 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 08/29/2002 | WO2002037937A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002028867A3 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 08/29/2002 | WO2002022795A3 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 08/29/2002 | WO2002022621A3 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
| 08/29/2002 | WO2002022620A3 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin f2$g(a) antagonists |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002018324A3 Immunoregulatory compounds, derivatives thereof and their use |
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2002002525A3 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 08/29/2002 | WO2002000641A3 Spla2 inhibitors |
| 08/29/2002 | WO2002000227A3 Use of lanthanum compounds for the treatment of bone diseases |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001095943A3 Prodrug compounds with an oligopeptide having an isoleucine residue |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001062238A3 Ppar gamma agonists for the treatment of liver inflammatory disorders |
| 08/29/2002 | WO2001042462A9 Phospholipase a2 inhibitory peptides from python reticulatus |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO2001005792A9 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
| 08/29/2002 | WO2000059515A9 Immunomodulating polymers |
| 08/29/2002 | WO2000037502A9 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 08/29/2002 | WO2000010981A9 Quinazoline derivatives |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 08/29/2002 | US20020120123 Human vascular endothelial growth factor 2 |
| 08/29/2002 | US20020120013 Regulation of phospholipase D activity |
| 08/29/2002 | US20020119999 Imidazole dione or one, thione derivatives as antitumor and antiinflammatory agents, also treats cardiovascular disease, nephropathies and retinopathies |
| 08/29/2002 | US20020119997 Aqueous solution; topical applying |
| 08/29/2002 | US20020119994 LFA-1 Antagonist compounds |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119987 Analgesics, anesthetic; side effect reduction |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119976 Tetracyclic derivatives, process of preparation and use |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119971 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |